United States Biosimilars Business and Investment Opportunities Report 2023: Market is Expected to Grow at a CAGR of 30.7% to Reach $11,316.0 Million by 2027 - ResearchAndMarkets.com
Retrieved on:
Thursday, April 20, 2023
Health, Biotechnology, Oncology, Community diagnostic centre, Magnetic resonance, Chromatography, Type, Electrophoresis, Clifton Springs Hospital & Clinic, Interferon, Others, Recombinant, Procedure, Cell, Mass spectrometry, Hospital, United, Insulin, Chronic, Magnetic resonance imaging, Infection, Generic drug, Fine chemical, Medical imaging, Semiconductor
1 United States Biosimilar Market Size and Forecast, 2018-2027
Key Points:
- 1 United States Biosimilar Market Size and Forecast, 2018-2027
2 United States Biosimilar Market Share by Product, 2018-2027
2.1 Biosimilar Market Size by Monoclonal Antibody Biosimilars, 2018-2027
2.2 Biosimilar Market Size by Insulin Biosimilar, 2018-2027
2.3 Biosimilar Market Size by Biosimilar Interferons, 2018-2027
2.4 Biosimilar Market Size by Other Biosimilars, 2018-2027
3 United States Biosimilar Market Share by Monoclonal Antibody Biosimilars, 2018-2027
4 United States Biosimilar Market Share by Insulin Biosimilars, 2018-2027
5 United States Biosimilar Market Share by Interferons Biosimilars, 2018-2027
6 United States Biosimilar Market Share by Other Biosimilars, 2018-2027
7 United States Biosimilar Market Share by Type of Cell, 2018-2027
7.1 Biosimilar Market Size by Mammalian Cell, 2018-2027
7.2 Biosimilar Market Size by Non-Mammalian Cell, 2018-2027
8 United States Biosimilar Market Share by Imaging Technique, 2018-2027
8.1 Biosimilar Market Size by Magnetic Resonance Imaging Scanners, 2018-2027
8.2 Biosimilar Market Size by Computed Tomography Scanners, 2018-2027
8.3 Biosimilar Market Size by Positron Emission Tomography Scanners, 2018-2027
8.4 Biosimilar Market Size by Others, 2018-2027
9 United States Biosimilar Market Share by Procedure, 2018-2027
9.1 Biosimilar Market Size by Invasive Procedure, 2018-2027
9.2 Biosimilar Market Size by Non-Invasive Procedure, 2018-2027
10 United States Biosimilar Market Share by Source of Manufacturing, 2018-2027
10.1 Biosimilar Market Size by In-House, 2018-2027
10.2 Biosimilar Market Size by Contract Manufacturing, 2018-2027
11 United States Biosimilar Market Share by Applications, 2018-2027
11.1 Biosimilar Market Size by Oncology, 2018-2027
11.2 Biosimilar Market Size by Blood Disorders, 2018-2027
11.3 Biosimilar Market Size by Growth Hormonal Deficiency, 2018-2027
11.4 Biosimilar Market Size by Chronic & Autoimmune Disorders, 2018-2027
11.5 Biosimilar Market Size by Infectious Diseases, 2018-2027
11.6 Biosimilar Market Size by Others, 2018-2027
12 United States Biosimilar Market Share by Type of Technology, 2018-2027
12.1 Biosimilar Market Size by Mass Spectroscopy, 2018-2027
12.2 Biosimilar Market Size by Chromatography, 2018-2027
12.3 Biosimilar Market Size by Recombinant DNA Technology, 2018-2027
12.4 Biosimilar Market Size by Electrophoresis, 2018-2027
12.5 Biosimilar Market Size by Others, 2018-2027
13 United States Biosimilar Market Share by End User, 2018-2027
13.1 Biosimilar Market Size by Hospital & Clinics, 2018-2027
13.2 Biosimilar Market Size by Diagnostic Centres, 2018-2027
13.3 Biosimilar Market Size by Others, 2018-2027